Article info

Download PDFPDF
Modifier controls severity of a novel dominant low-frequency MyosinVIIA (MYO7A) auditory mutation
  1. Correspondence to:
 Dr V Street
 Box 357923, V.M. Bloedel Hearing Research Center, Otolaryngology – HNS Department, University of Washington, Seattle, WA 98195; vastreetu.washington.edu
View Full Text

Citation

Street VA, Kallman JC, Kiemele KL
Modifier controls severity of a novel dominant low-frequency MyosinVIIA (MYO7A) auditory mutation

Publication history

  • First published April 30, 2004.
Online issue publication 
April 27, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.